Cutler Group LP Personalis, Inc. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$12.24 - $21.25 $7,344 - $12,750	-600 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$16.69 - $26.05 $35,049 - $54,705	-2,100 Reduced 77.78%	600 $0
Q2 2021 Jul 19, 2021	SELL	$18.15 - $27.75 $74,415 - $113,775	-4,100 Reduced 60.29%	2,700 $0
Q1 2021 Apr 26, 2021	SELL	$20.71 - $51.02 $2,071 - $5,102	-100 Reduced 1.45%	6,800 $11,000
Q4 2020 Jan 21, 2021	BUY	$21.84 - $44.0 $78,624 - $158,400	3,600 Added 109.09%	6,900 $55,000
Q3 2020 Oct 27, 2020	BUY	$13.63 - $24.12 $25,897 - $45,828	1,900 Added 135.71%	3,300 $10,000
Q2 2020 Jul 22, 2020	BUY	$7.65 - $14.11 $3,825 - $7,055	500 Added 55.56%	1,400 $3,000
Q1 2020 May 07, 2020	BUY	$4.75 - $12.41 $4,275 - $11,169	900 New	900 $0

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $159M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.